$NRX Pharmaceuticals Inc.(NRXP_老虎社区_美港股上老虎

https://lastfuturist.com/can-zyesami-treatment-reduce-mortality-rates-for-delta/?fbclid=IwAR3NpN3A5FQc2kJXx6AGPYe_eskJTn8K3c4jlTKUzjDfc4LKTjeHhUYhhvk

In the interview, Dr Javitt mentioned FDA wanted them to submit randomized controlled data, on top of their initial open-label data, and PR on Monday and the number we saw today was the randomized controlled data, and it seems very promising.

The slide that Dr Javitt showed with heading of:

“Zyesami demonstrates clear biologic effect in preventing IL-6 “Cytokine Storm” and then the chart showing Zyesami/Aviptadil treated patients were nearly 1,000% better off in IL-6 level than placebo patients really caught the attention of one of the other presenters who had been singing the praises of Regeneron MABs a few minutes earlier. they asked at least twice “Has this been published…where can I see this data”. This news just needs to go out far and wide in a much more publicized PR. NRXP strong!

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":172948180,"tweetId":"172948180","gmtCreate":1626930339340,"gmtModify":1631887103242,"author":{"id":3571296090030717,"idStr":"3571296090030717","authorId":3571296090030717,"authorIdStr":"3571296090030717","name":"ikool","avatar":"https://static.tigerbbs.com/3e0eb2d4ec1ae628be8e4acc7b5712d4","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":60,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/NRXP\">$NRX Pharmaceuticals Inc.(NRXP)$</a>https://lastfuturist.com/can-zyesami-treatment-reduce-mortality-rates-for-delta/?fbclid=IwAR3NpN3A5FQc2kJXx6AGPYe_eskJTn8K3c4jlTKUzjDfc4LKTjeHhUYhhvkIn the interview, Dr Javitt mentioned FDA wanted them to submit randomized controlled data, on top of their initial open-label data, and PR on Monday and the number we saw today was the randomized controlled data, and it seems very promising.The slide that Dr Javitt showed with heading of:“Zyesami demonstrates clear biologic effect in preventing IL-6 “Cytokine Storm” and then the chart showing Zyesami/Aviptadil treated patients were nearly 1,000% better off in IL-6 level than placebo patients really caught the attention of one of the other presenters who had been singing the praises of Regeneron MABs a few minutes earlier. they asked at least twice “Has this been published…where can I see this data”. This news just needs to go out far and wide in a much more publicized PR. NRXP strong!</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/NRXP\">$NRX Pharmaceuticals Inc.(NRXP)$</a>https://lastfuturist.com/can-zyesami-treatment-reduce-mortality-rates-for-delta/?fbclid=IwAR3NpN3A5FQc2kJXx6AGPYe_eskJTn8K3c4jlTKUzjDfc4LKTjeHhUYhhvkIn the interview, Dr Javitt mentioned FDA wanted them to submit randomized controlled data, on top of their initial open-label data, and PR on Monday and the number we saw today was the randomized controlled data, and it seems very promising.The slide that Dr Javitt showed with heading of:“Zyesami demonstrates clear biologic effect in preventing IL-6 “Cytokine Storm” and then the chart showing Zyesami/Aviptadil treated patients were nearly 1,000% better off in IL-6 level than placebo patients really caught the attention of one of the other presenters who had been singing the praises of Regeneron MABs a few minutes earlier. they asked at least twice “Has this been published…where can I see this data”. This news just needs to go out far and wide in a much more publicized PR. NRXP strong!</body></html>","text":"$NRX Pharmaceuticals Inc.(NRXP)$ https://lastfuturist.com/can-zyesami-treatment-reduce-mortality-rates-for-delta/?fbclid=IwAR3NpN3A5FQc2kJXx6AGPYe_eskJTn8K3c4jlTKUzjDfc4LKTjeHhUYhhvk In the interview, Dr Javitt mentioned FDA wanted them to submit randomized controlled data, on top of their initial open-label data, and PR on Monday and the number we saw today was the randomized controlled data, and it seems very promising. The slide that Dr Javitt showed with heading of: “Zyesami demonstrates clear biologic effect in preventing IL-6 “Cytokine Storm” and then the chart showing Zyesami/Aviptadil treated patients were nearly 1,000% better off in IL-6 level than placebo patients really caught the attention of one of the other presenters who had been singing the praises of Regeneron MABs a few minutes earlier. they asked at least twice “Has this been published…where can I see this data”. This news just needs to go out far and wide in a much more publicized PR. NRXP strong!","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":6,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/172948180","repostId":0,"isVote":1,"tweetType":1,"viewCount":1091,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NRXP"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":844,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/172948180"}